Inhibition or stimulation of immediate, spontaneous rosette formation at various SRBC:lymphocyte ratios. 1980

E Skopińska, and M Nowaczyk, and A Zółtowska, and J Wojtulewicz-Kurkus, and E Wierzchowska

The active rosette-forming cell (ARFC) percentage was investigated in a group of 100 persons, consisting of 50 healthy blood donors, 30 cancer patients (CA), and 20 patients suffering from rheumatoid arthritis (RA). The test was repeatedly performed using five SRBC:lymphocyte ratios: 10:1, 20:1, 5-:1, 100:1, and 200:1. In 18% of healthy donors and 30-40% of cancer patients, contrary to the remaining persons no relation between ARFC percentage and the SRBC:lymphocyte ratio was found. The "optimal" SRBC:lymphocyte ratio, varied from group to group and was 20:1 for most of RA patients, 50:1 for most of CA patients and 100:1 for most of healthy people. Sometimes, at higher SRBC:lymphocyte ratios a significant lowering of the ARFC percentage was found in relation to the optimal proportion for a given person, and this was observed for 200:1 ratio in 68% of healthy people, 54% of cancer patients and 90% of patients with RA. It is suggested, that ARFC test should be always performed at least in these three SRBC:lymphocyte ratios. Inhibition or stimulation of rosette formation by supernatant fluids of lymphocytes and SRBC suggest that SRBC release substances, which can directly or indirectly inhibit or stimulate rosette formation.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001984 Bronchial Neoplasms Tumors or cancer of the BRONCHI. Neoplasms, Bronchial,Bronchial Neoplasm,Neoplasm, Bronchial
D004906 Erythrocyte Count The number of RED BLOOD CELLS per unit volume in a sample of venous BLOOD. Blood Cell Count, Red,Erythrocyte Number,Red Blood Cell Count,Count, Erythrocyte,Counts, Erythrocyte,Erythrocyte Counts,Erythrocyte Numbers
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females

Related Publications

E Skopińska, and M Nowaczyk, and A Zółtowska, and J Wojtulewicz-Kurkus, and E Wierzchowska
February 1975, The New England journal of medicine,
E Skopińska, and M Nowaczyk, and A Zółtowska, and J Wojtulewicz-Kurkus, and E Wierzchowska
January 1978, Padiatrie und Grenzgebiete,
E Skopińska, and M Nowaczyk, and A Zółtowska, and J Wojtulewicz-Kurkus, and E Wierzchowska
September 1976, Laboratory investigation; a journal of technical methods and pathology,
E Skopińska, and M Nowaczyk, and A Zółtowska, and J Wojtulewicz-Kurkus, and E Wierzchowska
June 1979, Medical biology,
E Skopińska, and M Nowaczyk, and A Zółtowska, and J Wojtulewicz-Kurkus, and E Wierzchowska
January 1982, Fiziologicheskii zhurnal,
E Skopińska, and M Nowaczyk, and A Zółtowska, and J Wojtulewicz-Kurkus, and E Wierzchowska
May 1977, Cancer,
E Skopińska, and M Nowaczyk, and A Zółtowska, and J Wojtulewicz-Kurkus, and E Wierzchowska
April 1980, Clinical immunology and immunopathology,
E Skopińska, and M Nowaczyk, and A Zółtowska, and J Wojtulewicz-Kurkus, and E Wierzchowska
October 1975, Cryobiology,
E Skopińska, and M Nowaczyk, and A Zółtowska, and J Wojtulewicz-Kurkus, and E Wierzchowska
January 1976, Immunology,
E Skopińska, and M Nowaczyk, and A Zółtowska, and J Wojtulewicz-Kurkus, and E Wierzchowska
February 1979, Vrachebnoe delo,
Copied contents to your clipboard!